Nutrition support and therapy in patients with head and neck squamous cell carcinomas

Current Gastroenterology Reports

Volumn 14, Issue 4, 2012, Pages 349-355

  Gee, Arvin C ^a   Kiraly, Laszlo ^b   McCarthy, Mary S ^c   Martindale, Robert ^b  

^a LEGACY EMANUEL MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c Madigan Healthcare System   (United States)

Author keywords

Head and neck squamous cell carcinomas; Nutrition in head and neck cancer; Nutrition support

Indexed keywords

ALANYLGLUTAMINE; ARGININE; GLUTAMINE; LYCOPENE; OMEGA 3 FATTY ACID; PLACEBO;

ARTICLE; CANCER MORTALITY; DIET SUPPLEMENTATION; DYSPHAGIA; ENTERIC FEEDING; HEAD AND NECK CARCINOMA; HUMAN; IMMUNOMODULATION; MUCOSA INFLAMMATION; NONHUMAN; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; POSTOPERATIVE INFECTION; PROTEIN CALORIE MALNUTRITION; SQUAMOUS CELL CARCINOMA; SURGICAL INFECTION; SYSTEMATIC REVIEW;

ARGININE; CARCINOMA, SQUAMOUS CELL; CAROTENOIDS; FATTY ACIDS, OMEGA-3; HEAD AND NECK NEOPLASMS; HUMANS; MALNUTRITION; NUTRITION ASSESSMENT; NUTRITIONAL SUPPORT;

EID: 84865646752     PISSN: 15228037     EISSN: 1534312X     Source Type: Journal    
DOI: 10.1007/s11894-012-0273-5     Document Type: Article

References (53)

1. Society AC. Cancer Facts & Figures 2012. Atlanta: American Cancer Society; 2012.
2. Scully C. Oral cancer aetiopathogenesis; past, present and future aspects. Med Oral, Patol Oral Y Cir Bucal. 2011;16(3):e306-11.
3. Einstein MH, Schiller JT, Viscidi RP, Strickler HD, Coursaget P, Tan T, et al. Clinician's guide to human papillomavirus immunology: Knowns and unknowns. Lancet Infect Dis. 2009;9(6):347-56. doi:10.1016/S1473-3099(09)70108- 2.
4. Li G, Sturgis EM. The role of human papillomavirus in squamous carcinoma of the head and neck. Curr Oncol Rep. 2006;8(2):130-9.
5. Gillison ML, Broutian T, Pickard RK, Tong ZY, Xiao W, Kahle L, et al. Prevalence of oral HPV infection in the United States, 2009-2010. JAMA. 2012;307(7):693-703. doi:10.1001/jama.2012.101.
6. Cerchietti LC, Navigante AH, Lutteral MA, Castro MA, Kirchuk R, Bonomi M, et al. Double-blinded, placebo-controlled trial on intravenous L-alanyl-L-glutamine in the incidence of oral mucositis following chemoradiotherapy in patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2006;65(5):1330-7. doi:10.1016/j.ijrobp.2006.03.042. (Pubitemid 44425223)
7. Capuano G, Grosso A, Gentile PC, Battista M, Bianciardi F, Di Palma A, et al. Influence of weight loss on outcomes in patients with head and neck cancer undergoing concomitant chemoradiotherapy. Head Neck. 2008;30(4):503-8. doi:10.1002/hed.20737. (Pubitemid 351578755)
8. van Bokhorst-de van der S, van Leeuwen PA, Kuik DJ, Klop WM, Sauerwein HP, Snow GB, et al. The impact of nutritional status on the prognoses of patients with advanced head and neck cancer. Cancer. 1999;86(3):519-27. doi:10.1002/(SICI)1097-0142 (19990801)86:3<519::AID-CNCR22>3.0.CO;2-S. (Pubitemid 29347416)
9. Colasanto JM, Prasad P, Nash MA, Decker RH, Wilson LD. Nutritional support of patients undergoing radiation therapy for head and neck cancer. Oncology (Williston Park). 2005;19(3):371-9. discussion 80-2, 87. (Pubitemid 350054579)
10. Cox JD, Pajak TF, Marcial VA, Coia L, Mohiuddin M, Fu KK, et al. Interruptions adversely affect local control and survival with hyperfractionated radiation therapy of carcinomas of the upper respiratory and digestive tracts. New evidence for accelerated proliferation from Radiation Therapy Oncology Group Protocol 8313. Cancer. 1992;69(11):2744-8.
11. Paccagnella A, Morello M, Da Mosto MC, Baruffi C, Marcon ML, Gava A, et al. Early nutritional intervention improves treatment tolerance and outcomes in head and neck cancer patients undergoing concurrent chemoradiotherapy. Support Care Cancer. 2010;18(7):837-45. doi:10.1007/s00520-009-0717-0. This study demonstrated that initiation of pretherapy nutritional support lead to a decreased weight loss and the number of unplanned hospitalizations. Additionally, the study demonstrated increased tolerance to external beam radiation therapy.
12. Rabinovitch R, Grant B, Berkey BA, Raben D, Ang KK, Fu KK, et al. Impact of nutrition support on treatment outcome in patients with locally advanced head and neck squamous cell cancer treated with definitive radiotherapy: A secondary analysis of RTOG trial 90-03. Head Neck. 2006;28(4):287-96. doi:10.1002/hed.20335.
13. Ravasco P, Monteiro-Grillo I, Marques Vidal P, Camilo ME. Impact of nutrition on outcome: A prospective randomized controlled trial in patients with head and neck cancer undergoing radiotherapy. Head Neck. 2005;27(8):659-68. doi:10.1002/ hed.20221. (Pubitemid 41113766)
14. Scully C, Epstein J, Sonis S. Oral mucositis: A challenging complication of radiotherapy, chemotherapy, and radiochemotherapy: Part 1, pathogenesis and prophylaxis of mucositis. Head Neck. 2003;25(12):1057-70. doi:10.1002/hed.10318. (Pubitemid 37475269)
15. StokmanMA, Spijkervet FK, BoezenHM, Schouten JP, Roodenburg JL, deVries EG. Preventive intervention possibilities in radiotherapyand chemotherapy-induced oral mucositis: Results of meta-analyses. J Dent Res. 2006;85(8):690-700 (Pubitemid 44297322)
16. Kubota A, Meguid MM, Hitch DC. Amino acid profiles correlate diagnostically with organ site in three kinds of malignant tumors. Cancer. 1992;69(9):2343-8.
17. Garcia-Peris P, Paron L, Velasco C, de la Cuerda C, Camblor M, Breton I, et al. Long-term prevalence of oropharyngeal dysphagia in head and neck cancer patients: Impact on quality of life. Clin Nutr. 2007;26(6):710-7. doi:10.1016/j.clnu.2007.08.006. Retrospective study of patients who have undergone treatment for HNSCC. The authors are able to detail the effects of HNSCC treatment on dysphagia and quality of life. (Pubitemid 350082500)
18. Lango MN, Egleston B, Ende K, Feigenberg S, D'Ambrosio DJ, Cohen RB, et al. Impact of neck dissection on long-term feeding tube dependence in patients with head and neck cancer treated with primary radiation or chemoradiation. Head Neck. 2010;32(3):341-7. doi:10.1002/hed.21188. This is a retrospective study in which up to 75% of HNSCC patients who underwent a major surgical resection remained dependent on a feeding tube for nutritional support at 2 years after completion of therapy.
19. Chang JH, Gosling T, Larsen J, Powell S, Scanlon R, Chander S. Prophylactic gastrostomy tubes for patients receiving radical radiotherapy for head and neck cancers: A retrospective review. J Med Imaging Radiat Oncol. 2009;53(5):494-9. doi:10.1111/j.1754-9485.2009.02103.x.
20. Loser C, Aschl G, Hebuterne X, Mathus-Vliegen EM, Muscaritoli M, Niv Y, et al. ESPEN guidelines on artificial enteral nutrition-percutaneous endoscopic gastrostomy (PEG). Clin Nutr. 2005;24 (5):848-61. (Pubitemid 41403642)
21. Moor JW, Patterson J, Kelly C, Paleri V. Prophylactic gastrostomy before chemoradiation in advanced head and neck cancer: A multiprofessional web-based survey to identify current practice and to analyse decision making. Clin Oncol (R Coll Radiol). 2010;22 (3):192-8. doi:10.1016/j.clon.2010.01.008.
22. Paleri V, Patterson J. Use of gastrostomy in head and neck cancer: A systematic review to identify areas for future research. Clin Otolaryngol. 2010;35(3):177-89. doi:10.1111/ j.1749-4486.2010.02128.x. 354 Curr Gastroenterol Rep (2012) 14:349-355
23. Cruz I, Mamel JJ, Brady PG, Cass-Garcia M. Incidence of abdominal wall metastasis complicating PEG tube placement in untreated head and neck cancer. Gastrointest Endosc. 2005;62(5):708-11. doi:10.1016/j.gie.2005.06.041. quiz 52, 53. (Pubitemid 41502996)
24. Patterson J, Wilson JA. The clinical value of dysphagia preassessment in the management of head and neck cancer patients. Curr Opin Otolaryngol Head Neck Surg. 2011;19(3):177-81. doi:10.1097/MOO.0b013e328345aeb0.
25. Corry J, Poon W, McPhee N, Milner AD, Cruickshank D, Porceddu SV, et al. Prospective study of percutaneous endoscopic gastrostomy tubes versus nasogastric tubes for enteral feeding in patients with head and neck cancer undergoing (chemo)radiation. Head Neck. 2009;31(7):867-76. doi:10.1002/hed. 21044.
26. Madhoun MF, Blankenship MM, Blankenship DM, Krempl GA, Tierney WM. Prophylactic PEG placement in head and neck cancer: How many feeding tubes are unused (and unnecessary)? World J Gastroenterol. 2011;17(8):1004-8. doi:10.3748/ wjg.v17.i8.1004. This prospective study compared patients who received a prophylactic PEG tube to those who were treated with a nasogastric tube. The authors found that while a PEG tube lead to a decreased amount of posttherapy weight loss, patients who received a prophylactic tube had a longer time of dependence on tube feeds and were also more likely to develop longterm dysphagia.
27. Nourissat A, Bairati I, Samson E, Fortin A, Gelinas M, Nabid A, et al. Predictors of weight loss during radiotherapy in patients with stage I or II head and neck cancer. Cancer. 2010;116(9):2275-83. doi:10.1002/cncr.25041. The authors in this study were able to determine that nearly 50% of patients who underwent the prophylactic placement of a PEG tube either did not use the tube or used it for less than 2 weeks. The authors strongly argue against routine placement of a PEG tube prior to HNSCC therapy.
28. Nugent B, Lewis S, O'Sullivan JM. Enteral feeding methods for nutritional management in patients with head and neck cancers being treated with radiotherapy and/or chemotherapy. Cochrane Database Syst Rev. 2010(3):CD007904. doi :10.1002/ 14651858.CD007904.pub2.
29. Detsky AS, McLaughlin JR, Baker JP, Johnston N, Whittaker S, Mendelson RA, et al. What is subjective global assessment of nutritional status? JPEN J Parenter Enteral Nutr. 1987;11(1):8-13. (Pubitemid 17009508)
30. O'Neill JP, Shaha AR. Nutrition management of patients with malignancies of the head and neck. Surg Clin North Am. 2011;91(3):631-9. doi:10.1016/j.suc. 2011.02.005.
31. van Bokhorst-de van der Schueren MA, van Leeuwen PA, Sauerwein HP, Kuik DJ, Snow GB, Quak JJ. Assessment ofmalnutrition parameters in head and neck cancer and their relation to postoperative complications. Head Neck. 1997;19(5):419-25. doi:10.1002/(SICI) 1097-0347(199708)19:5<419::AID- HED9>3.0.CO;2-2. (Pubitemid 27293225)
32. Boger RH. The pharmacodynamics of L-arginine. J Nutr. 2007;137(6 Suppl 2):1650S-5S. A prospective study that show that preoperative malnutrition was common in HNSCC patients, and that this chronic malnutrition lead to an increased risk of postoperative complications. (Pubitemid 46855525)
33. Zhou M, Martindale RG. Arginine in the critical care setting. J Nutr. 2007;137(6 Suppl 2):1687S-92S. (Pubitemid 46855531)
34. de Luis DA, Izaola O, Cuellar L, Terroba MC, Martin T, Aller R. Clinical and biochemical outcomes after a randomized trial with a high dose of enteral arginine formula in postsurgical head and neck cancer patients. Eur J Clin Nutr. 2007;61(2):200-4. doi:10.1038/ sj.ejcn.1602515.
35. De Luis DA, Izaola O, Cuellar L, Terroba MC, Martin T, Aller R. High dose of arginine enhanced enteral nutrition in postsurgical head and neck cancer patients. A randomized clinical trial. Eur Rev Med Pharmacol Sci. 2009;13(4):279-83. This is a small randomized control trial that demonstrated benefit to arginine supplementation. These researchers noted a significant decrease in the rate of fistula formation after surgical resection of oral and laryngeal cancer.
36. De Luis DA, Izaola O, Cuellar L, Terroba MC, Martin T, Ventosa M. A randomized double-blind clinical trial with two different doses of arginine enhanced enteral nutrition in postsurgical cancer patients. Eur Rev Med Pharmacol Sci. 2010;14(11):941-5.
37. van Bokhorst-De Van Der Schueren MA, Quak JJ, von Blombergvan der Flier BM, Kuik DJ, Langendoen SI, Snow GB, et al. Effect of perioperative nutrition, with and without arginine supplementation, on nutritional status, immune function, postoperative morbidity, and survival in severely malnourished head and neck cancer patients. Am J Clin Nutr. 2001;73(2):323-32. (Pubitemid 32109863)
38. Buijs N, Langius JA, Leemans CR, Kuik DJ, Vermeulen MA, et al. Perioperative arginine-supplemented nutrition in malnourished patients with head and neck cancer improves long-term survival. Am J Clin Nutr. 2010;92(5):1151-6. doi:10.3945/ajcn.2010.29532.
39. Pribis JP, Zhu X, Vodovotz Y, Ochoa JB. Systemic arginine depletion after a murine model of surgery or trauma. JPEN J Parenter Enteral Nutr. 2012;36(1):53-9. doi:10.1177/0148607111414579. The authors of this randomized control trial were able to show that arginine supplementation, in addition to standard nutritional support, in chronically malnourished patients undergoing HNSCC treatment had improved survival and locoregional disease control. All of the patients in this study received enteral nutrition via a nasogastric tube for 710 days prior to onset of therapy and those in the arginine arm, did not receive arginine supplementation for more than 10 days in the postoperative period.
40. Sippel TR, White J, Nag K, Tsvankin V, Klaassen M, Kleinschmidt-DeMasters BK, et al. Neutrophil degranulation and immunosuppression in patients with GBM: Restoration of cellular immune function by targeting arginase I. Clin Cancer Res. 2011;17(22):6992-7002. doi:10.1158/1078-0432.CCR-11-1107.
41. Stechmiller JK, Childress B, Porter T. Arginine immunonutrition in critically ill patients: A clinical dilemma. Am J Crit Care: An official publication, American Association of Critical-Care Nurses. 2004;13(1):17-23. (Pubitemid 39456762)
42. Kim H. Glutamine as an immunonutrient. Yonsei Med J. 2011;52 (6):892-7. doi:10.3349/ymj.2011.52.6.892.
43. Ryan AM, Reynolds JV, Healy L, Byrne M, Moore J, Brannelly N, et al. Enteral nutrition enriched with eicosapentaenoic acid (EPA) preserves lean body mass following esophageal cancer surgery: Results of a double-blinded randomized controlled trial. Ann Surg. 2009;249(3):355-63. doi:10.1097/SLA. 0b013e31819a4789.
44. Senkal M, Geier B, Hannemann M, Deska T, Linseisen J, Wolfram G, et al. Supplementation of omega-3 fatty acids in parenteral nutrition beneficially alters phospholipid fatty acid pattern. JPEN J Parenter Enteral Nutr. 2007;31(1):12-7. (Pubitemid 46036292)
45. Tsekos E, Reuter C, Stehle P, Boeden G. Perioperative administration of parenteral fish oil supplements in a routine clinical setting improves patient outcome after major abdominal surgery. Clin Nutr. 2004;23(3):325-30. doi:10.1016/j.clnu.2003.07.008. (Pubitemid 38811669)
46. Wichmann MW, Thul P, Czarnetzki HD, Morlion BJ, Kemen M, Jauch KW. Evaluation of clinical safety and beneficial effects of a fish oil containing lipid emulsion (Lipoplus, MLF541): Data from a prospective, randomized, multicenter trial. Crit Care Med. 2007;35 (3):700-6. doi:10.1097/01.CCM. 0000257465.60287.AC. (Pubitemid 46407781)
47. Weed HG, Ferguson ML, Gaff RL, Hustead DS, Nelson JL, Voss AC. Lean body mass gain in patients with head and neck squamous cell cancer treated perioperatively with a protein-and energy-dense nutritional supplement containing eicosapentaenoic acid. Head Neck. 2011;33(7):1027-33. doi:10.1002/hed.21580.
48. De Stefani E, Oreggia F, Boffetta P, Deneo-Pellegrini H, Ronco A, Mendilaharsu M. Tomatoes, tomato-rich foods, lycopene and cancer of the upper aerodigestive tract: A case-control in Uruguay. Oral Oncol. 2000;36(1):47-53.
49. Andic F, Garipagaoglu M, Yurdakonar E, Tuncel N, Kucuk O. Lycopene in the prevention of gastrointestinal toxicity of radiotherapy. Nutr Cancer. 2009;61(6):784-8. doi:10.1080/01635580903285171.
50. Marik PE, Zaloga GP. Immunonutrition in high-risk surgical patients: A systematic review and analysis of the literature. JPEN J Parenter Enteral Nutr. 2010;34(4):378-86. doi:10.1177/0148607110362692.
51. Casas-Rodera P, Gomez-Candela C, Benitez S, Mateo R, Armero M, Castillo R, et al. Immunoenhanced enteral nutrition formulas in head and neck cancer surgery: A prospective, randomized clinical trial. Nutr Hosp. 2008;23(2):105-10. (Pubitemid 351879617)
52. Felekis D, Eleftheriadou A, Papadakos G, Bosinakou I, Ferekidou E, Kandiloros D, et al. Effect of perioperative immunoenhanced enteral nutrition on inflammatory response, nutritional status, and outcomes in head and neck cancer patients undergoing major surgery. Nutr Cancer. 2010;62(8):1105-12. doi:10.1080/ 01635581.2010.494336. This study found that an " immuneenhancing" formula and an arginine supplemented formula were equivalent in their ability to reduce the risk of HNSCC patients developing postoperative complications and infections as compared to a "standard" formula. The study was not able to identify any differences in biochemical markers used for nutritional status or for inflammation.
53. Sorensen D, McCarthy M, Baumgartner B, Demars S. Perioperative immunonutrition in head and neck cancer. Laryngoscope. 2009;119(7):1358-64. doi:10.1002/lary.20494. This study also supports the use of " immuneenhancing" formulas in the perioperative period for HNSCC patients. The authors of this study also were unable to detect any changes in biochemical markers of patients in the study group as compared to the control group.